Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice

Saved in:
Bibliographic Details
Published in:Digestive and liver disease 2020-11, Vol.52 (11), p.1250-1251
Main Authors: Prentice, Ralley E., Al-Ani, Aysha H, Bond, Katherine, Johnson, Doug, Christensen, Britt
Format: Article
Language:English
Subjects:
Betacoronavirus
Biological Therapy - adverse effects
Coronavirus Infections
Correspondence
COVID-19
Humans
Immunization
Inflammatory Bowel Diseases - diagnosis
Inflammatory Bowel Diseases - drug therapy
Pandemics
Pneumonia, Viral
SARS Virus
SARS-CoV-2
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1590-8658
1878-3562
DOI:10.1016/j.dld.2020.08.035